PDB16 A POPULATION-ADJUSTED INDIRECT COMPARISON OF CARDIOVASCULAR BENEFITS BETWEEN ONCE-WEEKLY SEMAGLUTIDE AND DULAGLUTIDE IN PATIENTS WITH TYPE 2 DIABETES AND HIGH CARDIOVASCULAR RISK

May 1, 2020, 00:00 AM
10.1016/j.jval.2020.04.204
https://www.valueinhealthjournal.com/article/S1098-3015(20)30392-2/fulltext
Section Title :
Section Order : 10059
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)30392-2&doi=10.1016/j.jval.2020.04.204
HEOR Topics :
Tags :
Regions :